Rapid Fire Marketing Announces the First Shipment of its Vapor Inhaler Model Named the CannaCig Has Passed All Patient Tests; Second Round of Production to Start This Week
2012 APR 28 - (VerticalNews.com) -- Rapid Fire Marketing (Pink Sheets: RFMK) announced that the Vapor Inhaler's CannaCig model has passed all tests, including actual trials done by medical marijuana patients over the weekend. Additionally, pre-orders for the Vapor Inhaler's CannaCig model have been coming in through VInhaler.com and the distributor side of Rapid Fire Marketing's website. A substantial marketing effort has been underway through the weekend, and will be stepped up this week and beyond, to build interest and awareness of the CannaCig. Marketing includes viral campaigns, street marketing and product posters which include one already visible on Hollywood Blvd. in Los Angeles which has substantial traffic. The CannaCig will be available at Otherside Health Management and Tabu Smoke Shops starting today. Otherside expects to sell out of our first trial run before the week's end and Tabu is already requesting more units. The Vapor Inhaler CannaCig model will be distributed nationwide after the next order arrives.
"We are ready to move forward now with full production of the Vapor Inhaler's first model which we named the CannaCig. There are specific actions being taken in anticipation of our next order's delivery. This week we will set up our distributor program including following up on solid leads that we want to act on quickly. We have talked to several distributors that want the CannaCig as soon as possible. Next, we will set up our online store and an affiliate program for websites to sell the unit, minus the active ingredient of course," said Tom Allinder, CEO of Rapid Fire Marketing.
The clear success of the CannaCig is prompting Rapid Fire Marketing to order a second round of production. The size of the production is set to be 500 units but could grow depending on the final count of pre-orders and interested vendors. Production cost will now be reduced to $30.00 per unit while the pricing structure will remain the same, with a retail price of $99.95 per empty unit and $120.00 with the active agent.
"The effort to transform this company into a structured entity and viable brand name is under way. The business plan is almost complete. I am being persistent with the DTCC to discover a reason for the chill and have it removed. Obviously, we need to achieve larger production runs but that can only be done through the growth financing I have been speaking of over the last couple months. That continues to be a big focus of mine and will be until we have a deal in place that enables us to do large production runs, introduce our new products and hire more staff," said Allinder.
"I would like to send a big thanks to Judah Neiditch at Otherside Health Management for all the hard work. None of this could have been possible without his tireless dedication in bringing this CannaCig project to the market. We sure had more than our fair share of obstacles but Judah worked through them all. I am so happy to be working with such a dedicated and resourceful individual," Allinder concluded.
"Wow! What a weekend it has been. We have had quite a few medical marijuana patients come through Otherside over the testing period and they all agree that this is the best unit on the market. Many who used the Vapor Inhaler during our launch event requested to take a unit home and committed to return today and get one of their own. I personally use it everywhere I can, with who ever will try it, and the response is always the same: 'Where can I get one?' These are going to sell out fast. My drive now is to ensure everyone, everywhere, can use this great device and will not rest until it has reached every continent on the planet," said Judah Neiditch of Otherside Health Management.
This article was prepared by VerticalNews Marketing editors from staff and other reports. Copyright 2012, VerticalNews Marketing via VerticalNews.com.